Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]:
SEC Accession No. 0001933414-25-000112
Filing Date
2025-09-02
Accepted
2025-09-02 20:51:52
Documents
16
Effectiveness Date
2025-09-02

Document Format Files

Seq Description Document Type Size
1 S-3MEF mlys-formsx3mef.htm S-3MEF 45837
2 mlysfeeexhibit.htm   iXBRL EX-FILING FEES 36184
3 EX-5.1 exhibit51-sx3mef.htm EX-5.1 27926
4 EX-23.1 exhibit231-sx3mef.htm EX-23.1 2072
5 image_0.jpg GRAPHIC 10826
6 lathamwatkinsa.jpg GRAPHIC 8253
  Complete submission text file 0001933414-25-000112.txt   278423

Data Files

Seq Description Document Type Size
18 EXTRACTED XBRL INSTANCE DOCUMENT mlysfeeexhibit_htm.xml XML 9912
Mailing Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087
Business Address 150 N. RADNOR CHESTER ROAD SUITE F200 RADNOR PA 19087 (888) 378-6240
Mineralys Therapeutics, Inc. (Filer) CIK: 0001933414 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3MEF | Act: 33 | File No.: 333-289998 | Film No.: 251287523
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)